3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 25 0 0 0 0 0 0 0999 V2000
2.1735 -0.8452 -0.2515 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4884 0.7872 -0.2120 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0527 -1.5547 -0.0382 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2180 2.4229 -0.1683 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3000 -2.2574 0.1771 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.3223 0.6887 0.1707 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1963 0.1440 -0.3878 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7879 0.8732 0.8057 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6320 -0.1038 0.0411 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8021 -0.5216 -0.1632 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8300 1.0603 -0.1237 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3543 -1.2098 0.0449 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8060 0.0936 0.0075 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1967 0.4226 0.0976 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0856 0.7206 -1.3026 H 0 0 0 0 0 0 0 0 0 0 0 0
3.4583 0.5857 1.7966 H 0 0 0 0 0 0 0 0 0 0 0 0
4.0042 1.9281 0.6910 H 0 0 0 0 0 0 0 0 0 0 0 0
5.4197 0.2927 -0.5875 H 0 0 0 0 0 0 0 0 0 0 0 0
4.8679 -1.0468 0.5189 H 0 0 0 0 0 0 0 0 0 0 0 0
2.3866 -1.8359 -0.2192 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.4714 3.0996 -0.2725 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.0397 2.7117 0.3480 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.8036 -2.2479 1.0598 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9337 -2.3416 -0.6128 H 0 0 0 0 0 0 0 0 0 0 0 0
1 7 1 0 0 0 0
1 10 1 0 0 0 0
1 20 1 0 0 0 0
2 10 1 0 0 0 0
2 11 2 0 0 0 0
3 10 2 0 0 0 0
3 12 1 0 0 0 0
4 11 1 0 0 0 0
4 21 1 0 0 0 0
4 22 1 0 0 0 0
5 12 1 0 0 0 0
5 23 1 0 0 0 0
5 24 1 0 0 0 0
6 14 3 0 0 0 0
7 8 1 0 0 0 0
7 9 1 0 0 0 0
7 15 1 0 0 0 0
8 9 1 0 0 0 0
8 16 1 0 0 0 0
8 17 1 0 0 0 0
9 18 1 0 0 0 0
9 19 1 0 0 0 0
11 13 1 0 0 0 0
12 13 2 0 0 0 0
13 14 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
4,6-diamino-2-(cyclopropylamino)pyrimidine-5-carbonitrile
4.2 InChl
InChI=1S/C8H10N6/c9-3-5-6(10)13-8(14-7(5)11)12-4-1-2-4/h4H,1-2H2,(H5,10,11,12,13,14)
4.3 InChlKey
PKTIFYGCWCQRSX-UHFFFAOYSA-N
4.4 Canonical SMILES
C1CC1NC2=NC(=C(C(=N2)N)C#N)N
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病